181 related articles for article (PubMed ID: 19342453)
21. Truncated variants of pig somatostatin receptor subtype 5 (sst5) act as dominant-negative modulators for sst2-mediated signaling.
Durán-Prado M; Gahete MD; Delgado-Niebla E; Martínez-Fuentes AJ; Vázquez-Martínez R; García-Navarro S; Gracia-Navarro F; Malagon MM; Luque RM; Castaño JP
Am J Physiol Endocrinol Metab; 2012 Dec; 303(11):E1325-34. PubMed ID: 23032684
[TBL] [Abstract][Full Text] [Related]
22. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
[TBL] [Abstract][Full Text] [Related]
23. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.
Parmar RM; Chan WW; Dashkevicz M; Hayes EC; Rohrer SP; Smith RG; Schaeffer JM; Blake AD
Biochem Biophys Res Commun; 1999 Sep; 263(2):276-80. PubMed ID: 10491284
[TBL] [Abstract][Full Text] [Related]
24. Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells.
Chen L; Fitzpatrick VD; Vandlen RL; Tashjian AH
J Biol Chem; 1997 Jul; 272(30):18666-72. PubMed ID: 9228036
[TBL] [Abstract][Full Text] [Related]
25. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
[TBL] [Abstract][Full Text] [Related]
26. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.
Ben-Shlomo A; Schmid H; Wawrowsky K; Pichurin O; Hubina E; Chesnokova V; Liu NA; Culler M; Melmed S
J Clin Endocrinol Metab; 2009 Nov; 94(11):4342-50. PubMed ID: 19820006
[TBL] [Abstract][Full Text] [Related]
27. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.
Timossi C; Ortiz-Elizondo C; Pineda DB; Dias JA; Conn PM; Ulloa-Aguirre A
Mol Cell Endocrinol; 2004 Aug; 223(1-2):17-26. PubMed ID: 15279907
[TBL] [Abstract][Full Text] [Related]
28. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
Barbieri F; Pattarozzi A; Gatti M; Porcile C; Bajetto A; Ferrari A; Culler MD; Florio T
Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118
[TBL] [Abstract][Full Text] [Related]
29. A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs.
Durán-Prado M; Saveanu A; Luque RM; Gahete MD; Gracia-Navarro F; Jaquet P; Dufour H; Malagón MM; Culler MD; Barlier A; Castaño JP
J Clin Endocrinol Metab; 2010 May; 95(5):2497-502. PubMed ID: 20233783
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory control of growth hormone secretion by somatostatin in rat pituitary GC cells: sst(2) but not sst(1) receptors are coupled to inhibition of single-cell intracellular free calcium concentrations.
Cervia D; Petrucci C; Bluet-Pajot MT; Epelbaum J; Bagnoli P
Neuroendocrinology; 2002 Aug; 76(2):99-110. PubMed ID: 12169771
[TBL] [Abstract][Full Text] [Related]
31. [New medical treatments in pituitary adenomas].
Drutel A; Caron P; Archambeaud F
Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
[TBL] [Abstract][Full Text] [Related]
32. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects.
Park S; Kamegai J; Kineman RD
Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release.
Cervia D; Fiorini S; Pavan B; Biondi C; Bagnoli P
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):200-9. PubMed ID: 11882916
[TBL] [Abstract][Full Text] [Related]
34. Identification of amino acids that are selectively involved in Gi/o activation by rat melanin-concentrating hormone receptor 1.
Hamamoto A; Kobayashi Y; Saito Y
Cell Signal; 2015 Apr; 27(4):818-27. PubMed ID: 25617691
[TBL] [Abstract][Full Text] [Related]
35. cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.
Peverelli E; Giardino E; Mangili F; Treppiedi D; Catalano R; Ferrante E; Sala E; Locatelli M; Lania AG; Arosio M; Spada A; Mantovani G
Cancer Lett; 2018 Oct; 435():101-109. PubMed ID: 30098401
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.
Buscail L; Estève JP; Saint-Laurent N; Bertrand V; Reisine T; O'Carroll AM; Bell GI; Schally AV; Vaysse N; Susini C
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1580-4. PubMed ID: 7878022
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells.
Lauder H; Sellers LA; Fan TP; Feniuk W; Humphrey PP
Br J Pharmacol; 1997 Oct; 122(4):663-70. PubMed ID: 9375962
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptors.
Benali N; Ferjoux G; Puente E; Buscail L; Susini C
Digestion; 2000; 62 Suppl 1():27-32. PubMed ID: 10940684
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20.
Tallent M; Liapakis G; O'Carroll AM; Lolait SJ; Dichter M; Reisine T
Neuroscience; 1996 Apr; 71(4):1073-81. PubMed ID: 8684611
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.
Petrucci C; Cervia D; Buzzi M; Biondi C; Bagnoli P
Br J Pharmacol; 2000 Feb; 129(3):471-84. PubMed ID: 10711345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
